Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$298.57M
Total Bought:
$2.54M
Total Sold:
$99.82M
Net Transaction:
-$97.28M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nu Holdings Ltd.CL A(NU)9,155,6617,328,294-1,827,367$109.23M$94.46M31.64%-$14.77M
Klaviyo, Inc.COM SER A(KVYO)3,514,8973,516,221+1,324$89.56M$87.52M29.31%-$2.04M
DoorDash, Inc.CL A(DASH)523,091423,091-100,000$72.04M$46.02M15.41%-$26.02M
UiPath, Inc.CL A(PATH)2,303,4521,155,246-1,148,206$52.22M$14.65M4.91%-$37.57M
Snowflake Inc.CL A(SNOW)215,615108,304-107,311$34.84M$14.63M4.90%-$20.21M
Acrivon Therapeutics Inc1,652,6052,122,605+470,000$11.82M$12.31M4.12%+$495.0K
10x Genomics, Inc.CL A(TXG)481,770481,7700$18.08M$9.37M3.14%-$8.71M
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,417,0750$13.84M$8.27M2.77%-$5.57M
Tarsus Pharmaceuticals, Inc.(TARS)170,000170,0000$6.18M$4.62M1.55%-$1.56M
Candel Therapeutics, Inc.(CADL)811,737405,837-405,900$1.28M$2.52M0.84%+$1.23M
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$2.08M$1.62M0.54%-$456.7K
908 Devices Inc.(MASS)237,258237,2580$1.79M$1.22M0.41%-$569.4K
Spruce Biosciences Inc787,007787,0070$621.7K$409.2K0.14%-$212.5K
Coupang, Inc.CL A(CPNG)11,93111,9310$212.3K$250.0K0.08%+$37.7K
Absci Corporation57,80457,8040$328.3K$178.0K0.06%-$150.3K
Samsara Inc.CL A(IOT)3,5704,239+669$134.9K$142.9K0.05%+$7.9K
Datadog, Inc.CL A(DDOG)1,0151,0150$125.5K$131.6K0.04%+$6.2K
Toast, Inc.CL A(TOST)5,9474,945-1,002$148.2K$127.4K0.04%-$20.8K
CrowdStrike Holdings, Inc.CL A(CRWD)279221-58$89.4K$84.7K0.03%-$4.8K
GitLab Inc.CL A(GTLB)6586580$38.4K$32.7K0.01%-$5.7K
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q2 2024 | TickerTrail